EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Multizentrische Studie

Immunotherapy followed by cetuximab in locally advanced/metastatic cutaneous squamous cell carcinomas: the I-TACKLE trial

Paolo Bossi, Andrea Alberti, Cristiana Bergamini, Carlo Resteghini, Laura Deborah Locati, Salvatore Alfieri, Stefano Cavalieri, Elena Colombo, Cristina Gurizzan, Luigi Lorini, Valeria Tovazzi, Manuel Zamparini und 7 weitere

European Journal of Cancer · 2025

DOI: 10.1016/j.ejca.2025.115379 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift European Journal of Cancer, 2025. Verfasst von Paolo Bossi und 18 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, via Manzoni 56, Milan, Rozzano 20089, Italy; Department of Biomedical Scienc…. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Squamous Cell, Cetuximab. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Merck Sharp and Dohme United Kingdom, MSD.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, Monoclonal, HumanizedAntineoplastic Combined Chemotherapy ProtocolsCarcinoma, Squamous CellCetuximabImmunotherapySkin NeoplasmsAdultAgedAged, 80 and overFemaleHumansMaleMiddle Aged

Stichwörter der Autor:innen

CetuximabCutaneous squamous cell carcinomaPembrolizumabResistance to immune-checkpoint inhibitors

Substanzen

Antibodies, Monoclonal, HumanizedCetuximabpembrolizumab

Autor:innen und Institutionen

  • Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, via Manzoni 56, Milan, Rozzano 20089, Italy; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Milan, Pieve Ema…
  • Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia at the Azienda Socio Sanitaria Territoriale (ASST)-Spedali Civili, Brescia, Italy.
  • Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, via Giacomo Venezian 1, Milan 20133, Italy.
  • Department of Internal Medicine and Medical Therapy, University of Pavia, Pavia 27100, Italy; Translational Oncology Unit, Maugeri Clinical Research Institutes IRCCS, Pavia 27100, Italy.
  • Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, via Giacomo Venezian 1, Milan 20133, Italy; Department of Oncology and Hemato-oncology, University of Milan, via Santa…
  • Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, via Manzoni 56, Milan, Rozzano 20089, Italy.

Förderung

  • Merck Sharp and Dohme United Kingdom
  • MSD

Zitieren

APA

Bossi, P., Alberti, A., Bergamini, C., Resteghini, C., Locati, L. D., Alfieri, S., Cavalieri, S., Colombo, E., Gurizzan, C., Lorini, L., Tovazzi, V., Zamparini, M., Ravanelli, M., Ascierto, P. A., Rampinelli, V., Grammatica, A., Patuzzo, R., Maurichi, A., & Licitra, L. F. (2025). Immunotherapy followed by cetuximab in locally advanced/metastatic cutaneous squamous cell carcinomas: the I-TACKLE trial. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2025.115379

Vancouver

Bossi P, Alberti A, Bergamini C, Resteghini C, Locati LD, Alfieri S, et al. Immunotherapy followed by cetuximab in locally advanced/metastatic cutaneous squamous cell carcinomas: the I-TACKLE trial. European Journal of Cancer. 2025. doi:10.1016/j.ejca.2025.115379

BibTeX
@article{Bossi2025,
  author = {Bossi, Paolo and Alberti, Andrea and Bergamini, Cristiana and Resteghini, Carlo and Locati, Laura Deborah and Alfieri, Salvatore and Cavalieri, Stefano and Colombo, Elena and Gurizzan, Cristina and Lorini, Luigi and Tovazzi, Valeria and Zamparini, Manuel and Ravanelli, Marco and Ascierto, Paolo Antonio and Rampinelli, Vittorio and Grammatica, Alberto and Patuzzo, Roberto and Maurichi, Andrea and Licitra, Lisa Francesca},
  title = {Immunotherapy followed by cetuximab in locally advanced/metastatic cutaneous squamous cell carcinomas: the I-TACKLE trial},
  journal = {European Journal of Cancer},
  year = {2025},
  doi = {10.1016/j.ejca.2025.115379}
}
Kostenlos starten →